SCHEMBL25458809

SCHEMBL25458809

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)oc4cc(-c6ccc(-c7ccccc7)c7c6sc6ccccc67)ccc45)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.38
ALOX5 P09917 1/20 0.36
LIMK1 P53667 3/20 0.34
ESR2 Q92731 2/20 0.33
TNKS O95271 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
F9 P00740 1/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HCRTR1 O43613 1/20 0.31
SLC9A1 P19634 1/20 0.31
ATM Q13315 1/20 0.30
MMP12 P39900 1/20 0.30
MMP13 P45452 1/20 0.30
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25458805 1.00 PRKDC (0.38) PRKDCALOX5LIMK1ESR2TNKS
SCHEMBL26762687 0.99 PRKDC (0.39) PRKDCALOX5LIMK1ESR2TNKS
SCHEMBL26215398 0.99 PRKDC (0.39) PRKDCALOX5LIMK1ESR2TNKS
SCHEMBL26248142 0.97 PRKDC (0.39) PRKDCALOX5LIMK1ESR2F9
SCHEMBL26763253 0.97 PRKDC (0.39) PRKDCALOX5LIMK1ESR2F9
SCHEMBL25458681 0.96 PRKDC (0.36) PRKDCALOX5LIMK1ESR2MAPT
SCHEMBL25458674 0.96 PRKDC (0.36) PRKDCALOX5LIMK1ESR2MAPT
SCHEMBL26763576 0.96 PRKDC (0.36) PRKDCALOX5LIMK1ESR2MAPT
SCHEMBL26763567 0.96 PRKDC (0.39) PRKDCALOX5LIMK1ESR2HCRTR1
SCHEMBL26763559 0.96 PRKDC (0.39) PRKDCALOX5LIMK1ESR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed
US-20230157151-A1 ORGANIC ELECTROLUMINESCENT APPARATUS MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230157151-A1 ORGANIC ELECTROLUMINESCENT APPARATUS MERCK PATENT GMBH (DE) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, ODC1 PRKDC 4160/4885ALOX5 309/4885LIMK1 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.